Best Practices in NTM-PD: A Patient-Centered Approach to Diagnosis, Treatment and Improved Adherence

Released On
June 25, 2020

Expires On
June 25, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Infectious Disease

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by National Jewish Health.

 

Supported by an educational grant from Insmed.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

This activity contains four 15-minute chapters each worth .25 credit. Learners can consume all or part of the segments.

Target Audience

Pulmonologists, infectious disease physicians, primary care physicians, nurse practitioners, and physician assistants

Program Overview

Nontuberculous mycobacteria (NTM) is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM and new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, guideline-based treatment, personalized treatment selection for patients, and managing adverse events and improving patient adherence are discussed using video presentation of challenging cases.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Employ a guideline-based best practice approach to an early and accurate diagnosis of NTM
  • Apply patient-centered communication strategies regarding diagnosis, ongoing management, and treatment goals to manage patient expectations
  • Implement guideline-based strategies to manage adverse events and improve patient adherence

Faculty

FACULTY NAME and TITLE

Charles Daley, MD

Chief, Division of Mycobacterial and Respiratory Infections
Professor of Medicine
National Jewish Health
University of Colorado Denver
Denver, CO

FACULTY NAME and TITLE

Shannon H. Kasperbauer, MD

Associate Professor of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health
University of Colorado Denver
Denver, CO

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

National Jewish Health designates this online enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™; Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any relevant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty Disclosures

Charles Daley, MD discloses that he is an investigator for Insmed and Spero and a consultant for Meiji. He is on an advisory board for Insmed, Johnson and Johnson, Spero, Paratek, Cipla, and Matinas and on a data management committee for Otsuka.

Shannon H. Kasperbauer, MD discloses that she is a speaker and investigator for Insmed and on an advisory board for Insmed and AN2Therapeutics.

Planners and Reviewers Disclosures

Marie Carlson has no financial relationships to disclose.

Stephanie Corder, ND, RN has no financial relationships to disclose.

Jared J. Eddy, MD has no financial relationships to disclose.

Andrea Harshman, MHA, CHCP, CMP-HC has no financial relationships to disclose.

Kathy Herring has no financial relationships to disclose.

Anita Knight has no financial relationships to disclose.

Harold Nelson, MD discloses that he is on the data safety monitoring board for AstraZeneca.

Lauren Rieck has no financial relationships to disclose.

Instructions for Participation and Credit

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the learning objectives and disclosures
  2. Participate in the online activity.
  3. Complete the post-test and the evaluation form

If you successfully complete the post-test (score of 70% or higher), your certificate will be made available immediately. If you have any questions relating to the accreditation of this activity, please contact: proed@njhealth.org

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

Disclaimer

National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Privacy Policy

https://www.nationaljewish.org/education-training/pro-ed/privacy-policy-and-practices

The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME).

We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming.

If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities.

Updated NTM Guidelines

https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa241/5867961